Divalent metal transporter 1 (DMT1) in the brain: Implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology

Frontiers in Molecular Neuroscience

Volumn 8, Issue June, 2015, Pages

  Skjørringe, Tina ^a   Burkhart, Annette ^a   Johnsen, Kasper Bendix ^a   Moos, Torben ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Belgrade rat; Blood brain barrier; DMT1; Iron; OX26; Transferrin receptor

Indexed keywords

APOTRANSFERRIN; FERROPORTIN; INTERLEUKIN 6; IRON BINDING PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NON TRANSFERRIN BOUND IRON; TRANSFERRIN; UNCLASSIFIED DRUG;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CAPILLARY ENDOTHELIUM; DOWN REGULATION; ENDOTHELIUM CELL; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; IRON CHELATION; IRON DEFICIENCY; IRON TRANSPORT; NONHUMAN; OLIGODENDROGLIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; TRANSCYTOSIS; UPREGULATION; WESTERN BLOTTING;

EID: 84935859016     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2015.00019     Document Type: Review

References (96)

1. Abbott, N. J., Ronnbacck, L., and Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53. doi: 10.1038/nrn1824
2. Acikyol, B., Graham, R. M., Trinder, D., House, M. J., Olynyk, J. K., Scott, R. J., et al. (2013). Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience 235, 119-128. doi: 10.1016/j.neuroscience.2013.01.014
3. Agranoff, D., Collins, L., Kehres, D., Harrison, T., Maguire, M., and Krishna, S. (2005). The Nramp orthologue of Cryptococcus neoformans is a pH-dependent transporter of manganese, iron, cobalt and nickel. Biochem. J. 385, 225-232. doi: 10.1042/bj20040836
4. Anderson, G. J., and Vulpe, C. D. (2009). Mammalian iron transport. Cell. Mol. LifeSci. 66, 3241-3261. doi: 10.1007/s00018-009-0051-1
5. Andolfo, I., De Falco, L., Asci, R., Russo, R., Colucci, S., Gorrese, M., et al. (2010). Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells. Haematologica 95, 1244-1252. doi: 10.3324/haematol.2009.020685
6. Arredondo, M., Muñoz, P., Mura, C. V., and Núriez, M. T. (2003). DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 284,C1525-C1530. doi: 10.1152/ajpcell.00480.2002
7. Ayonrinde, O. T., Milward, E. A., Chua, A. C., Trinder, D., and Olynyk, J. K. (2008). Clinical perspectives on hereditary hemochromatosis. Crit. Rev. Clin. Lab. Sci. 45, 451-484. doi: 10.1080/10408360802335716
8. Bardou-Jacquet, E., Island, M. L., Jouanolle, A. M., Détivaud, L., Fatih, N., Ropert, M., et al. (2011). A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload. Blood Cells Mol. Dis. 47,243-248. doi: 10.1016/j.bcmd.2011.07.004
9. Bartzokis, G., Lu, P. H., Tingus, K., Peters, D. G., Amar, C. P., Tishler, T. A., et al. (2011). Gender and iron genes maymodifyassociations between brain iron and memory in healthy aging. Neuropsychopharmacology 36, 1375-1384. doi: 10.1038/npp.2011.22
10. Beaumont, C., Delaunay, J., Hetet, G., Grandchamp, B., de Montalembert, M., and Tchernia, G. (2006). Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia and liver iron overload. Blood 107, 4168-4170. doi: 10.1182/blood-2005-10-4269
11. Blanco, E., Kannengiesser, C., Grandchamp, B., Tasso, M., and Beaumont, C. . Not all DMT1 mutations lead to iron overload. Blood Cells Mol. Dis.43, 199-201. doi: 10.1016/j.bcmd.2009.05.003
12. Brightman, M. W., and Reese, T. S. (1969). Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 40, 648-677. doi: 10.1083/jcb.40.3.648
13. Brissot, P., Bardou-Jacquet, E., Jouanolle, A. M., and Loréal, O. (2011). Iron disorders of genetic origin: a changing world. Trends Mol. Med. 17, 707-713. doi: 10.1016/j.molmed.2011.07.004
14. Burdo, J. R., Martin, J., Menzies, S. L., Dolan, K. G., Romano, M. A., Fletcher, R. J., et al. (1999). Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93, 1189-1196. doi: 10.1016/s0306-4522(99)00207-9
15. Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G., et al. (2001). Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198-1207. doi: 10.1002/jnr.1256.abs
16. Burkhart, A. (2015). The Blood-Brain Barrier in vitro using Primary Culture: Implications for Studies of Therapeutic Gene Expression and Iron Transport. PhD-thesis. Denmark: River Publishers.
17. Canonne-Hergaux, F., Zhang, A. S., Ponka, P., and Gros, P. (2001). Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 98, 3823-3830. doi: 10.1182/blood.v98.13.3823
18. Cellier, M., Privé, G., Belouchi, A., Kwan, T., Rodrigues, V., Chia, W., et al. (1995). Nramp defines a family of membrane proteins. Proc. Natl. Acad. Sci. USA 92, 10089-10093. doi: 10.1073/pnas.92.22.10089
19. Cetin, I., Parisi, F., Berti, C., Mandò, C., and Desoye, G. (2012). Placental fatty acid transport in maternal obesity. J. Dev. Orig. Health Dis. 3, 409-414. doi: 10.1017/s2040174412000414
20. Chaloupka, R., Courville, P., Veyrier, F., Knudsen, B., Tompkins, T.A., and Cellier, M. F. (2005). Identification of functional amino acids in the Nramp family by a combination of evolutionary analysis and biophysical studies of metal and proton cotransport in vivo. Biochemistry 44, 726-733. doi: 10.1021/bi048014v
21. Chua, A. C., Graham, R. M., Trinder, D., and Olynyk, J. K. (2007). The regulation of cellular iron metabolism. Crit. Rev. Clin. Lab. Sci. 44, 413-459. doi: 10.1080/10408360701428257
22. Ciechanover, A., Schwartz, A. L., Dautry-Varsat, A., and Lodish, H. F. (1983). Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect oflysosomotropic agents. J. Biol. Chem. 258, 9681-9689
23. Conrad, M. E., and Umbreit, J. N. (2000). Iron absorption and transport-an update. Am. J. Hematol. 64, 287-298. doi: 10.1002/1096-8652(200008)64:4<287::aid-ajh9>3.0.co;2-l
24. Crowe, A., and Morgan, E. H. (1992). Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res. 592, 8-16. doi: 10.1016/0006-8993(92)91652-u
25. Dautry-Varsat, A., Ciechanover, A., and Lodish, H. F. (1983). pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. US A 80, 2258-2262. doi: 10.1073/pnas.80.8.2258
26. Enerson, B. E., and Drewes, L. R. (2006). The rat blood-brain barrier transcriptome. J. Cereb. Blood Flow Metab. 26, 959-973. doi: 10.1038/sj.jcbfm.9600249
27. Farcich, E. A., and Morgan, E. H. (1992). Diminished iron acquisition by cells and tissues ofBelgrade laboratory rats. Am. J. Physiol. 262, R220-R224
28. Fleming, M. D., Romano, M. A., Su, M. A., Garrick, L. M., Garrick, M. D., and Andrews, N. C. (1998). Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. USA 95, 1148-1153. doi: 10.1073/pnas.95.3.1148
29. Garrick, M. D., Kuo, H. C., Vargas, F., Singleton, S., Zhao, L., Smith, J. J., et al. (2006). Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. Biochem. J. 398, 539-546. doi: 10.1042/bj20051987
30. Garrick, M. D., Zhao, L., Roth, J. A., Jiang, H., Feng, J., Foot, N. J., et al. (2012). Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation. Biometals 25, 787-793. doi: 10.1007/s10534-012-9522-1
31. Garrido-Gil, P., Rodriguez-Pallares, J., Dominguez-Meijide, A., Guerra, M. J., and Labandeira-Garcia, J. L. (2013). Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells. Exp. Neurol. 250, 384-396. doi: 10.1016/j.expneurol.2013.10.013
32. Gruenheid, S., Cellier, M., Vidal, S., and Gros, P. (1995). Identification and characterization of a second mouse Nramp gene. Genomics 25, 514-525. doi: 10.1016/0888-7543(95)80053-o
33. Gunshin, H., Fujiwara, Y., Custodio, A. O., Direnzo, C., Robine, S., and Andrews, N. C. (2005). Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Invest. 115, 1258-1266. doi: 10.1172/jci24356
34. Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., et al. (1997). Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488. doi: 10.1038/41343
35. Harding, C., Heuser, J., and Stahl, P. (1983). Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97, 329-339. doi: 10.1083/jcb.97.2.329
36. Hentze, M. W., Muckenthaler, M. U., Galy, B., and Camaschella, C. (2010). Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24-38. doi: 10.1016/j.cell.2010.06.028
37. Howitt, J., Gysbers, A. M., Ayton, S., Carew-Jones, F., Putz, U., Finkelstein, D. I., et al. (2014). Increased Ndfip1 in the substantia nigra ofParkinsonian brains is associated with elevated iron levels. PLoS One 9:e87119. doi: 10.1371/journal.pone.0087119
38. Huang, E., Ong, W. Y., Go, M. L., and Connor, J. R. (2006). Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury. Exp. Brain Res. 170, 376-386. doi: 10.1007/s00221-005-0220-x
39. Hubert, N., and Hentze, M. W. (2002). Previously uncharacterized isoforms of divalent metal transporter (DMT)-1, implications for regulation and cellular function. Proc. Natl. Acad. Sci. USA 99, 12345-12350. doi: 10.1073/pnas.192423399
40. Ingrassia, R., Lanzillotta, A., Sarnico, I., Benarese, M., Blasi, F., Borgese, L., et al. (2012). 1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated byNF-kappaB/RelA acetylation at Lys310. PLoS One 7:e38019. doi: 10.1371/journal.pone.0038019
41. Iolascon, A., d’Apolito, M., Servedio, V., Cimmino, F., Piga, A., and Camaschella, C. (2006). Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107, 349-354. doi: 10.1182/blood-2005-06-2477
42. Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., and Mason, D. Y. (1984). Transferrin receptor on endothelium of brain capillaries. Nature 312, 162-163. doi: 10.1038/312162a0
43. Ji, C., and Kosman, D. J. (2015). Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons. J. Neurochem. 133,668-683.doi: 10.1111/jnc.13040
44. Jia, W., Xu, H., Du, X., Jiang, H., and Xie, J. (2015). Ndfip1 attenuated 6-OHDA-induced iron accumulationvia regulatingthe degradation ofDMT1. Neurobiol Aging 36, 1183-1193. doi: 10.1016/j.neurobiolaging.2014.10.021
45. Kacem, K., Lacombe, P., Seylaz, J., and Bonvento, G. (1998). Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: aconfocal microscopystudy. Glia 23, 1-10.doi: 10.1002/(sici)1098-1136(199805)23:1<1::aid-glia1>3.3.co;2-q
46. Ke, Y., Chang, Y. Z., Duan, X. L., Du, J. R., Zhu, L., Wang, K., et al. (2005). Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain. Neurobiol. Aging 26, 739-748. doi: 10.1016/j.neurobiolaging.2004.06.002
47. Kim, J., Buckett, P. D., and Wessling-Resnick, M. (2013).Absorption ofmanganese and iron in a mouse model of hemochromatosis. PLoS One 8:e64944. doi: 10.1371/journal.pone.0064944
48. Knutson, M. D. (2007). Steap proteins: implications for iron and copper metabolism. Nutr. Rev. 65,335-340. doi: 10.1111/j.1753-4887.2007.tb00311.x
49. Lam-Yuk-Tseung, S., Camaschella, C., Iolascon, A., and Gros, P. (2006). A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload blood cells. Mol. Dis. 36, 347-354. doi: 10.1016/j.bcmd.2006.01.011
50. Lam-Yuk-Tseung, S., Govoni, G., Forbes, J., and Gros, P. (2003). Iron transport by Nramp2/DMT1, pH regulation of transport by 2 histidines in transmembrane domain 6. Blood 101, 3699-3707. doi: 10.1182/blood-2002-07-2108
51. Lam-Yuk-Tseung, S., Mathieu, M., and Gros, P. (2005). Functional characterization of the E399D DMT1/NRAMP2/SLC11A2 protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload blood cells. Mol. Dis. 35, 212-216. doi: 10.1016/j.bcmd.2005.05.008
52. Lane, D. J., Robinson, S. R., Czerwinska, H., Bishop, G. M., and Lawen, A. (2010). Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem. J. 432, 123-132. doi: 10.1042/bj20101317
53. Lis, A., Barone, T. A., Paradkar, P. N., Plunkett, R. J., and Roth, J. A. (2004). Expression and localization of different forms of DMT1 in normal and tumor astroglial cells. Brain Res. Mol. Brain Res. 122, 62-70. doi: 10.1016/j.molbrainres.2003.11.023
54. Mackenzie, B., Takanaga, H., Hubert, N., Rolfs, A., and Hediger, M. A. (2007). Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem. J. 403, 59-69. doi: 10.1042/bj20061290
55. Makui, H., Roig, E., Cole, S. T., Helmann, J. D., Gros, P., and Cellier, M. F. (2000). Identification of the Escherichia coli K-12. Nramp orthologue (MntH) as a selective divalentmetaliontransporter. Mol. Microbiol. 35,1065-1078. doi: 10.1046/j.1365-2958.2000.01774.x
56. McCarthy, R. C., and Kosman, D. J. (2013). Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux. J. Biol. Chem. 288, 17932-17940. doi: 10.1074/jbc.m113.455428
57. McCarthy, R. C., Park, Y. H., and Kosman, D. J. (2014). sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 15, 809-815. doi: 10.15252/embr.201338064
58. Mims, M. P., Guan, Y., Pospisilova, D., Priwitzerova, M., Indrak, K., Ponka, P., et al. (2005). Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105, 1337-1342. doi: 10.1182/blood-2004-07-2966
59. Moos, T., and Morgan, E. H. (1998). Evidence for low molecular weight, non­transferrin-bound iron in rat brain and cerebrospinal fluid. J. Neurosci. Res. 54, 486-494. doi: 10.1002/(sici)1097-4547(19981115)54:4<486::aid-jnr6>3.0.co;2-i
60. Moos, T., and Morgan, E. H. (2000). Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20, 77-95. doi: 10.1023/A:1006948027674
61. Moos, T., and Morgan, E. H. (2001). Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat. J. Neurochem. 79, 119-129. doi: 10.1046/j.1471-4159.2001.00541.x
62. Moos, T., and Morgan, E. H. (2004). The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J. Neurochem. 88, 233-245. doi: 10.1046/j.1471-4159.2003.02142.x
63. Moos, T., Oates, P. S., and Morgan, E. H. (1998). Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. J. Comp. Neurol. 398, 420-430. doi: 10.1002/(sici)1096-9861(19980831)398:3<420::aid-cne8>3.0.co;2-1
64. Moos, T., Rosengren Nielsen, T., Skjorringe, T., and Morgan, E. H. (2007). Iron trafficking inside the brain. J. Neurochem. 103, 1730-1740. doi: 10.1111/j.1471-4159.2007.04976.x
65. Moos, T., Skjoerringe, T., Gosk, S., and Morgan, E. H. (2006). Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J. Neurochem. 98, 1946-1958. doi: 10.1111/j.1471-4159.2006.04023.x
66. Moos, T., Trinder, D., and Morgan, E. H. (2000). Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell. Mol. Biol. (Noisy-le-grand) 46, 549-561
67. Morgan, E. H. (1977). Iron exchange between transferrin molecules mediated by phosphate compounds and other cell metabolites. Biochim. Biophys. Acta 499, 169-177. doi: 10.1016/0304-4165(77)90239-2
68. Morgan, E. H. (1979). Studies on the mechanism of iron release from transferrin. Biochim. Biophys. Acta 580, 312-326. doi: 10.1016/0005-2795(79)90144-2
69. Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., et al. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093. doi: 10.1126/science.1104742
70. Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., et al. (2014). Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 81, 49-60. doi: 10.1016/j.neuron.2013.10.061
71. Pardridge, W. M. (2015). Blood-brain barrier drug delivery ofIgG fusion proteins with a transferrin receptor monoclonal antibody. Expert Opin. Drug Deliv. 12, 207-222. doi: 10.1517/17425247.2014.952627
72. Pelizzoni, I., Zacchetti, D., Smith, C. P., Grohovaz, F., and Codazzi, F. (2012). Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J. Neurochem. 120, 269-278. doi: 10.1111/j.1471-4159.2011.07578.x
73. Qian, Z. M., To, Y., Tang, P. L., and Feng, Y. M. (1999). Transferrin receptors on the plasma membrane of cultured rat astrocytes. Exp. Brain Res. 129, 473-476. doi: 10.1007/s002210050916
74. Roth, J. A., Singleton, S., Feng, J., Garrick, M., and Paradkar, P. N. (2010). Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. J. Neurochem. 113, 454-464. doi: 10.1111/j.1471-4159.2010.06607.x
75. Rouault, T. A. (2013). Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat. Rev. Neurosci. 14, 551-564. doi: 10.1038/nrn3453
76. Rouault, T. A., and Cooperman, S. (2006). Brain iron metabolism. Semin. Pediatr. Neurol. 13, 142-148. doi: 10.1016/j.spen.2006.08.002
77. Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., et al. (2008). Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease. Proc. Natl. Acad. Sci. USA 105, 18578-18583. doi: 10.1073/pnas.0804373105
78. Sharp, P., Tandy, S., Yamaji, S., Tennant, J., Williams, M., and Singh Srai, S. K. (2002). Rapid regulation of divalent metal transporter (DMT1) protein but not mRNA expression by non-haem iron in human intestinal Caco-2 cells. FEBS Lett. 510,71-76. doi: 10.1016/s0014-5793(01)03225-2
79. Shayeghi, M., Latunde-Dada, G. O., Oakhill, J. S., Laftah, A. H., Takeuchi, K., Halliday, N., et al. (2005). Identification of an intestinal heme transporter. Cell 122, 789-801. doi: 10.1016/j.cell.2005.06.025
80. Simpson, I. A., Ponnuru, P., Klinger, M. E., Myers, R. L., Devraj, K., Coe, C. L., et al. (2015). A novel model for brain iron uptake: introducing the concept of regulation. J. Cereb. Blood Flow Metab. 35, 48-57. doi: 10.1038/jcbfm.2014.168
81. Strahan, M. E., Crowe, A., and Morgan, E. H. (1992). Iron uptake in relation to transferrin degradation in brain and other tissues of rats. Am. J. Physiol. 263, R924-R929
82. Su, M. A., Trenor, C. C., Fleming, J. C., Fleming, M. D., and Andrews, N. C. (1998). The G185R mutation disrupts function of the iron transporter Nramp2. Blood 92,2157-2163
83. Taylor, E. M., Crowe, A., and Morgan, E. H. (1991). Transferrin and iron uptake bythe brain: effects of altered iron status. J. Neurochem. 57,1584-1592. doi: 10.1111/j.1471-4159.1991.tb06355.x
84. Taylor, E. M., and Morgan, E. H. (1990). Developmental changes in transferrin and iron uptake by the brain in the rat. Brain Res. Dev. Brain Res. 55, 35-42. doi: 10.1016/0165-3806(90)90103-6
85. Tchernitchko, D., Bourgeois, M., Martin, M. E., and Beaumont, C. (2002). Expression of the two mRNA isoforms of the iron transporter Nramp2/DMTI in mice and function of the iron responsive element. Biochem. J. 363, 449-455. doi: 10.1042/0264-6021:3630449
86. Thompson, K., Molina, R. M., Brain, J. D., and Wessling-Resnick, M. (2006). Belgrade rats display liver iron loading. J. Nutr. 136,3010-3014
87. Todorich, B., Pasquini, J. M., Garcia, C. I., Paez, P. M., and Connor, J. R. (2009). Oligodendrocytes and myelination: the role of iron. Glia 57, 467-478. doi: 10.1002/glia.20784
88. Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M., et al. (2013). Inflammation alters the expression of DMT1, FPN1 and hepcidin and it causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541-549. doi: 10.1111/jnc.12244
89. van Gelder, W., Huijskes-Heins, M. I., van Dijk, J. P., Cleton-Soeteman, M. I., and van Eijk, H. G. (1995). Quantification of different transferrin receptor pools in primarycultures of porcine blood-brain barrier endothelial cells. J. Neurochem. 64,2708-2715. doi: 10.1046/j.1471-4159.1995.64062708.x
90. Visser, C. C., Voorwinden, L. H., Crommelin, D. J., Danhof, M., and de Boer, A. G. (2004). Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm. Res. 21, 761-769. doi: 10.1023/b:pham.0000026425.69874.8e
91. Vulpe, C. D., Kuo, Y. M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., et al. (1999). Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21, 195-199. doi: 10.1038/5979
92. Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., and Zecca, L. (2014). The role ofiron in brain ageingand neurodegenerative disorders. LancetNeurol. 13, 1045-1060. doi: 10.1016/s1474-4422(14)70117-6
93. Worthen, C. A., and Enns, C. A. (2014). The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body. Front. Pharmacol. 5:34. doi: 10.3389/fphar.2014.00034
94. Xu, H., Jin, J., DeFelice, L. J., Andrews, N. C., and Clapham, D. E. (2004). A spontaneous, recurrent mutation in divalent metal transporter-1 exposes a calciumentrypathway. PLoSBiol. 2:E50. doi: 10.1371/journal.pbio.0020050
95. Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., et al. (2011). Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci. Transi. Med. 3:84ra44. doi: 10.1126/scitranslmed.3002230
96. Zhang, H. Y., Song, N., Jiang, H., Bi, M. X., and Xie, J. X. (2014). Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor inhibit ferrous iron influx via divalent metal transporter 1 and iron regulatory protein 1 regulation in ventral mesencephalic neurons. Biochim. Biophys. Acta 1843, 2967-2975. doi: 10.1016/j.bbamcr.2014.09.010